Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil.

3.2 Dose 1 ER and hospital visits showed an increasing trend starting prior to the administration of dose 1 of the mass vaccination campaign, with a slightly higher rate of visits in the six weeks after vaccination, when compared to the pre-vaccination period ( Fig. 1a ).

also in 63,971 other papers